Below is a list of research protocols that have been reviewed and approved by the IRB, ensuring compliance with ethical standards and guidelines.
Reference No.
Protocol Title
Principal Investigator
Date of Submission
Date of Approval
Action
Ref. RMC/IRB/2025/11
Comparison of Response and Toxicity of Induction Chemotherapy with FOLFIRINOX (5-Fluorouracil, Irinotecan, Oxalipatin, Folinic acid) vs CAPOX (Capecitabine and Oxaliplatin) followed by Long Course Concurrent Chemoradiation in Locally Advanced Rectal Cancer.
Dr. Purnoma Puja
26 Feb, 2025
29 May, 2025
Ref. RMC/IRB/2025/10
Bacterial Profile of Neonatal Septicemia and Its Antibiotic Susceptibility Pattern in Special Care Newborn Unit of Rajshahi Medical College Hospital.
Dr. Md. Hasan Ali Molla
16 Apr, 2025
29 May, 2025
Ref. RMC/IRB/2025/08
Immunohistochemical Expression of Cyclin D1 in Epithelial Ovarian Carcinoma and it’s Relation with Histpathologcal Grades
Dr. Susmita Mohanto
25 Jan, 2025
24 May, 2025
Ref. RMC/IRB/2025/08
Comparative Outcomes between Laser Hemorrhoidoplasty and Milligan-Morgan Hemorrhoidectomy.
Dr. Minhaj Al Noman
15 Apr, 2025
13 May, 2025
Ref. RMC/IRB/2025/07
Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Urothelial Carcinoma of Urinary Bladder & its Relation with Histopatholgical Grades
Dr. Popy Bhoumik
25 Jan, 2025
24 Apr, 2025
Ref. RMC/IRB/2025/09
Complete Blood Count Level in Apparently Healthy Adults Living in Rajshahi City.
Dr. Rubayat Sultana
19 Feb, 2025
24 Apr, 2025
Ref. RMC/IRB/2025/07
Study of Left Ventricular Diastolic Dysfunction in Patients with Type-2 Diabetes Mellitus.
Dr. Md. Asif Rahman
10 Mar, 2025
22 Apr, 2025
RMC/IRB/2025/05
Comparison of Response and Toxicity between 3 Fractions of 7.5 Gy Versus 2 Fractions of 9 Gy High Dose Rate Brachytherapy along with Concurrent Chemoradion in Locally Advanced Carcinoma Cervix
Dr. Afia Farhana
13 Jan, 2025
08 Apr, 2025
RMC/IRB/2025/03
Frequency of Development of Factor VIII Inhibitor in Patients with Hemophilia A Treated with Factor VIII Concentrates in a Tertiary Level Hospital in Bangladesh
Dr. Md. Abdus Salam
01 Jan, 2025
24 Mar, 2025
RMC/IRB/2025/06
Immunohistochemical Expression of CD44 in Oral Squamous Cell Carcinoma and Its Relation with Histopathological Grade
